Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks

All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?